Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | Anti-BCMA CAR T Cells |
Trade Name | |
Synonyms | CART-BCMA|CT053 |
Drug Descriptions |
Anti-BCMA CAR T Cells are T-cells that express a chimeric antigen receptor targeting B-cell maturation antigen (BCMA), which may induce an enhanced anti-tumor immune response against BCMA-expressing tumor cells (PMID: 23344265). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C156272 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Anti-BCMA CAR T Cells | Anti-BCMA CAR T Cells | 0 | 2 |
Anti-BCMA CAR T Cells + Cyclophosphamide + Fludarabine | Anti-BCMA CAR T Cells Cyclophosphamide Fludarabine | 0 | 2 |
Anti-BCMA CAR T Cells + Cyclophosphamide + Fludarabine + LY3039478 | Anti-BCMA CAR T Cells Cyclophosphamide Fludarabine LY3039478 | 0 | 1 |